Cefuroxime Supplier-Buyer Network — Trade Flow Analysis

Name: Cefuroxime Supplier-Buyer Trade Network Dataset — 440+ Indian Exporters, 20+ Importers, 150+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Cefuroxime supplier network, Cefuroxime buyers, pharmaceutical export India, Cefuroxime trade data

TransData Nexus

Cefuroxime

India Pharmaceutical Trade Intelligence

$129.6M440 Suppliers150 CountriesHS 30042019

ExportsIndia → UNITED STATES17.0%India → BRAZIL14.7%

ImportsITALY → India$797.7M UNITED KINGDOM → India$600.4K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: M/S. RANBAXY

Who Supplies Cefuroxime? Top Manufacturers & Buyers 2026 — SUN PHARMACEUTICAL INDUSTRIES LIMITED Leads | TransData Nexus | TransData Nexus

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Cefuroxime exporter from India, with a market share of 9.7% and a total export value of $12.6M across 336 shipments. Their average shipment value of $37.5K is above the market average of $18.6K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. M/S. RANBAXY FARMACEUTICA LTDA. is the dominant customer, accounting for 54.5% of this supplier's tracked business. Top customers include:

• M/S. RANBAXY FARMACEUTICA LTDA. — $6.9M across 183 shipments (54.5% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $3.1M across 84 shipments (25.0% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $1.0M across 27 shipments (8.2% of this supplier's total exports)

• M/S. RANBAXY FARMACEUTICA LTDA. — $980.0K across 26 shipments (7.8% of this supplier's total exports)

• M/S. RANBAXY FARMACEUTICA LTDA. — $579.3K across 15 shipments (4.6% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $37.5K is 101% above the market average of $18.6K, consistent with large-order contracts or value-added formulations.

2ALKEM LABORATORIES LIMITED

ALKEM LABORATORIES LIMITED is the second-largest Cefuroxime exporter from India, with a market share of 7.5% and a total export value of $9.7M across 231 shipments. Their average shipment value of $42.0K is above the market average of $18.6K, suggesting premium or bulk contract pricing.

ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ASCEND LABORATORIES,LLC — $4.3M across 104 shipments (44.9% of this supplier's total exports)

• ASCEND LABORATORIES,LLC — $2.2M across 54 shipments (23.2% of this supplier's total exports)

• ASCEND LABORATORIES,LLC — $1.6M across 37 shipments (16.0% of this supplier's total exports)

• THE PHARMA NETWORK — $1.2M across 28 shipments (12.3% of this supplier's total exports)

• ASCEND LABORATORIES,LLC — $346.8K across 8 shipments (3.6% of this supplier's total exports)

Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $42.0K is 125% above the market average of $18.6K, consistent with large-order contracts or value-added formulations.

3AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED is the third-largest Cefuroxime exporter from India, with a market share of 3.7% and a total export value of $4.8M across 266 shipments. Their average shipment value of $18.0K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• APL SWIFT SERVICES MALTA LIMITED — $1.6M across 88 shipments (33.2% of this supplier's total exports)

• AUROBINDO PHARMA USA INC — $1.0M across 57 shipments (21.3% of this supplier's total exports)

• APL SWIFT SERVICES (MALTA) LTD., — $865.0K across 48 shipments (18.1% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $746.9K across 42 shipments (15.6% of this supplier's total exports)

• RISING PHARMA HOLDIN — $562.0K across 31 shipments (11.8% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LIMITED operates with high shipment frequency (266 shipments) at a per-shipment value of $18.0K, indicating a broad distribution network with many smaller, regular orders.

4AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fourth-largest Cefuroxime exporter from India, with a market share of 2.9% and a total export value of $3.8M across 706 shipments. Their average shipment value of $5.3K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• APL SWIFT SERVICES (MALTA) LTD., — $1.1M across 211 shipments (29.9% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $902.4K across 169 shipments (23.9% of this supplier's total exports)

• AURO PHARMA INC, — $640.2K across 120 shipments (17.0% of this supplier's total exports)

• AUROBINDO PHARMA USA INC — $571.7K across 107 shipments (15.2% of this supplier's total exports)

• AUROLOGISTICS LLC, — $531.1K across 99 shipments (14.1% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (706 shipments) at a per-shipment value of $5.3K, indicating a broad distribution network with many smaller, regular orders.

5THEON PHARMACEUTICALS LIMITED

THEON PHARMACEUTICALS LIMITED is the fifth-largest Cefuroxime exporter from India, with a market share of 2.3% and a total export value of $2.9M across 586 shipments. Their average shipment value of $5.0K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.

THEON PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• GREEN CORE PHARMA IN — $674.3K across 135 shipments (23.1% of this supplier's total exports)

• ESKAY THERAPEUTICS LTD. — $622.4K across 125 shipments (21.3% of this supplier's total exports)

• ORANGE BIOTEC INC.UN — $588.0K across 118 shipments (20.1% of this supplier's total exports)

• SUHITAS PHARMACEUTIC — $545.8K across 109 shipments (18.7% of this supplier's total exports)

• GREEN CORE PHARMA IN — $494.8K across 99 shipments (16.9% of this supplier's total exports)

Key Insight: THEON PHARMACEUTICALS LIMITED operates with high shipment frequency (586 shipments) at a per-shipment value of $5.0K, indicating a broad distribution network with many smaller, regular orders.

6NECTAR LIFE SCIENCES LIMITED

NECTAR LIFE SCIENCES LIMITED is the fifth-largest Cefuroxime exporter from India, with a market share of 1.2% and a total export value of $1.6M across 120 shipments. Their average shipment value of $13.4K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.

NECTAR LIFE SCIENCES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CITIBANK, N.A. — $544.9K across 41 shipments (33.8% of this supplier's total exports)

• ASPEN PHARMACARE AUS — $400.6K across 30 shipments (24.8% of this supplier's total exports)

• BIOAVENIR — $339.7K across 25 shipments (21.1% of this supplier's total exports)

• LINFOX HEALTHCARE LO — $192.3K across 14 shipments (11.9% of this supplier's total exports)

• CITIBANK, N.A. — $135.1K across 10 shipments (8.4% of this supplier's total exports)

Key Insight: NECTAR LIFE SCIENCES LIMITED operates with high shipment frequency (120 shipments) at a per-shipment value of $13.4K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Cefuroxime imports from India, with a total trade value of $22.0M across 246 shipments — representing a 17.0% share of all Cefuroxime exports. The average shipment value of $89.4K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.

Named Cefuroxime importers in United States: ASCEND LABORATORIES, LLC is the largest buyer, accounting for 19.8% ($4.3M) of this market's total imports.

• ASCEND LABORATORIES, LLC — $4.3M (19.8% of United States's total)

• ASCEND LABORATORIES,LLC — $3.8M (17.1% of United States's total)

• ASCEND LABORATORIES LLC — $2.4M (11.0% of United States's total)

Key Insight: United States's per-shipment average of $89.4K (380% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Cefuroxime imports from India.

Primary Market

Secondary Market

2Brazil

Brazil ranks as the second-largest destination for Cefuroxime imports from India, with a total trade value of $19.0M across 81 shipments — representing a 14.7% share of all Cefuroxime exports. The average shipment value of $234.9K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Cefuroxime importers in Brazil: M/S. RANBAXY FARMACEUTICA LTDA : is the largest buyer, accounting for 49.0% ($9.3M) of this market's total imports.

• M/S. RANBAXY FARMACEUTICA LTDA : — $9.3M (49.0% of Brazil's total)

• M/S. RANBAXY FARMACEUTICA LTDA. — $1.4M (7.4% of Brazil's total)

Key Insight: Brazil's per-shipment average of $234.9K (1162% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Cefuroxime imports from India.

Primary Market

Secondary Market

3Philippines

Philippines ranks as the third-largest destination for Cefuroxime imports from India, with a total trade value of $12.9M across 0 shipments — representing a 10.0% share of all Cefuroxime exports. The average shipment value of $12.9M is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations.

Key Insight: Philippines's per-shipment average of $12.9M (69219% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Cefuroxime imports from India.

Primary Market

Secondary Market

4Nigeria

Nigeria ranks as the fourth-largest destination for Cefuroxime imports from India, with a total trade value of $11.3M across 21 shipments — representing a 8.7% share of all Cefuroxime exports. The average shipment value of $535.8K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cefuroxime importers in Nigeria: FIDSON HEALTHCARE PLC is the largest buyer, accounting for 12.7% ($1.4M) of this market's total imports.

• FIDSON HEALTHCARE PLC — $1.4M (12.7% of Nigeria's total)

Key Insight: Nigeria's per-shipment average of $535.8K (2777% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Nigeria is a key market for Cefuroxime imports from India.

Primary Market

Secondary Market

5Sri Lanka

Sri Lanka ranks as the fifth-largest destination for Cefuroxime imports from India, with a total trade value of $9.6M across 79 shipments — representing a 7.4% share of all Cefuroxime exports. The average shipment value of $121.7K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cefuroxime importers in Sri Lanka: BREATHEFREE LANKA PVT LTD is the largest buyer, accounting for 14.4% ($1.4M) of this market's total imports.

• BREATHEFREE LANKA PVT LTD — $1.4M (14.4% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $121.7K (553% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Cefuroxime imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cefuroxime.
2.Flow Mapping: 440 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 6,961 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 150 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

6,961 Verified Shipments

440 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Cefuroxime

Cefuroxime

Who Supplies Cefuroxime? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Cefuroxime? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Cefuroxime Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

2ALKEM LABORATORIES LIMITED

3AUROBINDO PHARMA LIMITED

4AUROBINDO PHARMA LTD

5THEON PHARMACEUTICALS LIMITED

6NECTAR LIFE SCIENCES LIMITED

From Indian Factories to Global Pharmacies — How Cefuroxime Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Cefuroxime Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Brazil

3Philippines

4Nigeria

5Sri Lanka

People Also Ask — Cefuroxime Supplier & Trade Network

Cefuroxime Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology